Volume 10.02 | Jan 21

ESC & iPSC News 10.02 January 21, 2015
ESC & iPSC News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC on Twitter
 
TOP STORY
GATA Family Members as Inducers for Cellular Reprogramming to Pluripotency
Researchers found that all members of the GATA family could inhibit overrepresented ectodermal-lineage genes, which is consistent with previous reports indicating that a balance of different lineage-specifying forces is important for the restoration of pluripotency. [Cell Res] Full Article
New TeSR™-E8™ is Here For Feeder-Free Culture of Human ES Cells and iPS Cells
 
PUBLICATIONS (Ranked by impact factor of the journal)
Epigenetic Predisposition to Reprogramming Fates in Somatic Cells
By tracing cell lineages from several divisions before factor induction through to pluripotent colony formation, researchers found that pre-induction sister cells acquire similar outcomes. Namely, if one daughter cell contributes to a lineage that generates induced pluripotent stem cells, its paired sibling will as well. [EMBO Rep] Abstract

Comparative Computational Analysis of Pluripotency in Human and Mouse Stem Cells
There are substantial differences in the regulation of pluripotency between human and mouse, and in humans only stem cells that resemble the primed state in mouse are readily available. Scientists developed a pipeline to reanalyze transcriptomics data sets that describe both states, naïve and primed pluripotency, in human and mouse. [Sci Rep] Full Article

No DNA Damage Response and Negligible Genome-Wide Transcriptional Changes in Human Embryonic Stem Cells Exposed to Terahertz Radiation
Investigators studied DNA damage and transcriptome responses in human embryonic stem cells exposed to narrow-band terahertz radiation under strict temperature control. [Sci Rep] Full Article

Differentiation of Primordial Germ Cells from Induced Pluripotent Stem Cells of Primary Ovarian Insufficiency
Scientists compared the differentiation ability of germ cells and the gene expression level of germ cell-related genes in the X chromosome deletion region of induced pluripotent stem cell (iPSC) lines derived from primary ovarian insufficiency patients with an iPSC line derived from normal fibroblasts. [Hum Reprod] Abstract

Mitochondrial and Metabolic Remodeling during Reprogramming and Differentiation of the Reprogrammed Cells
The authors investigated the cytoplasmic remodeling and changes in metabolism that occur during reprogramming and differentiation of pluripotent stem cells. Specifically, they examined the cellular organelles of three pluripotent stem cells, embryonic, induced pluripotent, and epiblast stem cells, by electron microscopy. [Stem Cells Dev] Abstract

Human Embryonic Stem Cells Form Functional Thyroid Follicles
The authors have shown that overexpression of the regulatory transcription factors Pax8 and Nkx2-1 directs murine embryonic stem (ES) cells to differentiate into thyroid follicular cells by initiating a transcriptional regulatory network. Here, they studied human ES cells with the aim of recapitulating this scenario and producing functional human thyroid cell lines. [Thyroid] Abstract

Defined Culture of Human Embryonic Stem Cells and Xeno-Free Derivation of Retinal Pigmented Epithelial Cells on a Novel, Synthetic Substrate
Scientists investigated the maintenance of human embryonic stem cells and their differentiation into retinal pigmented epithelium using Synthemax II-SC, which is a novel, synthetic animal-derived component-free, RGD peptide-containing copolymer compliant with good manufacturing practices designed for xeno-free stem cell culture. [Stem Cells Transl Med] Abstract

Transcription Activator-Like Effector Nuclease (TALEN)-Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual Reporter Human Induced Pluripotent Stem Cell (iPSC) and Neural Stem Cell (NSC) Lines
Investigators constructed TALENs targeting the safe-harbor like gene CLYBL to mediate reporter gene integration at 38%-58% efficiency, and used both AAVS1-TALENs and CLYBL-TALENs to simultaneously knock-in multiple reporter genes at dual safe-harbor loci in human iPSCs and NSCs. [PLoS One] Full Article

Request a Sample: ReproTeSR™
 
REVIEWS
Induced Pluripotency by Defined Factors: Prey of Oxidative Stress
The authors review mounting studies that have tackled reprogramming efficiency and genome stability of induced pluripotent stem cells. In particular, they focus on the effect of oxidative stress on cellular reprogramming. [Stem Cells] Abstract

Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.

Cell Culture World Congress 2015
 
INDUSTRY NEWS
Bone Therapeutics Demonstrates Efficacy in First Patient Cohort in ALLOB® Phase I/IIa Delayed-Union Trial
Bone Therapeutics announced positive efficacy results for the first cohort of four patients enrolled in the Phase I/IIa delayed-union trial with its allogeneic bone-forming cell product ALLOB®. [Bone Therapeutics]
Press Release

First Patient Successfully Transplanted with Cryopreserved (Frozen) NiCord® in Gamida Cell’s Ongoing Phase I/II Clinical Trial for Blood Cancers
Gamida Cell announced that the first person has been successfully transplanted with cryopreserved (frozen) NiCord® in the company’s ongoing Phase I/II clinical study for blood cancer patients. [Gamida Cell]
Press Release

From our sponsor: Free wallchart from Nature Neuroscience – Neural Stem Cells. Request your copy.
 
POLICY NEWS
Economists Offer New Arguments for U.S. Research Tax Break
Add another study to the sagging bookshelf of reports suggesting that the United States would benefit from permanently allowing companies to get a tax break for investing in research and development. [ScienceInsider] Editorial

A One-Grant Limit: NIH Institute Puts Squeeze on Flush Investigators
In the latest example of budget stretching at the National Institutes of Health (NIH), the agency’s basic science institute is imposing a strict one-grant limit on scientists who already have plentiful no-strings support. The move could free up at least $6 million, or 25 grants for other scientists. [ScienceInsider] Editorial

Science Gets Its Moment in Obama’s 2015 State of the Union
Science rarely makes a major appearance in the president’s annual State of the Union address. This year’s speech by President Barack Obama maintained that tradition—but he did take a few moments in the 60-minute address to stake out a strong defense of his administration’s policies to combat climate change, and to preview a new “precision medicine” initiative that aims to tap genetic and other information to improve treatments for human diseases. [ScienceInsider] Editorial
 
EVENTS
NEW Cellular Therapy 2015 – 8th International Symposium on the Clinical Use of Cellular Products
March 19-20, 2015
Erlangen, Germany

NEW 2nd International Congress on Stem Cell and Cellular Therapies (ICSCCT)
October 15-18, 2015
Antalya, Turkey

Visit our events page to see a complete list of events in the ESC & iPSC community.
 
JOB OPPORTUNITIES
NEW Director (California Institute for Regenerative Medicine)

Postdoctoral Positions – Human Embryonic Stem Cells and Induced Pluripotent Stem Cells (University of Macau)

Postdoctoral Fellow – Wnt Signaling and Cell Polarity in Embryonic Development (Icahn School of Medicine at Mount Sinai)

Research Technician – Skeletal Muscle Disorders with Human iPS Cells (Johns Hopkins University School of Medicine)

Postdoctoral Fellow – Pluripotent Stem Cells and Cartilage Biology (Boston Children’s Hospital)

PhD Studentship – Deciphering Mechanisms Underlying the Dysfunction of Motoneurons Derived from ALS Patient iPSCs (University of St. Andrews)

Postdoctoral Scientist – Stem Cell Models of Autism (University of South Carolina)

Postdoctoral Fellow – Stem Cell Biology and Reprogramming (Baylor College of Medicine)

Postdoctoral Fellow and Technician – Regenerative Medicine Using iPSC, Embryonic and Adult Stem Cells (University of Illinois at Chicago)

Postdoctoral Position – Pluripotent Stem Cell Biology and Cancer Research (Memorial Sloan-Kettering Cancer Center)

Scientist – Reprogramming and Pluripotent Stem Cell Biology (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Biology Endoderm Lineages (STEMCELL Technologies Inc.)

Scientist – Human Pluripotent Stem Cell Biology (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about ESC & iPSC News: Archives | Events | Contact Us